apposters.com
Connecticut Innovations
Edit

Connecticut Innovations

https://www.ctinnovations.com
Last activity: 15.06.2026
Active
Invests in categories: HealthTechTechnologyPlatformServiceDataFinTechEdTechCareManagementMedTech
The best ideas come out of collaboration. Not just when they’re brainstormed, but when they’re brought to life. At Connecticut Innovations, we help make great things happen by connecting entrepreneurs and established business owners with venture capitalists, angel investors, lenders and other resources—along with our own in-house capital and expertise. Working together, we can power progress.

Note:
This page is intended for positive discussion. Negativity, trolling and profanity will be deleted.
Likes
2.47K
Portfolio
294
Mentions
243
Location: United States, Indiana, New Haven
Employees: 51-200
Phone:+1 860-563-5851
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A; Grant

Portfolio 294

DateNameWebsiteTotal RaisedLocation
11.06.2026Rejuvenate...rejuvenatebio.com$10MUnited Sta...
22.05.2026Neurosoft ...neurosoft-bio.com$10.5MSwitzerlan...
17.03.2026Internet B...quorus.com$5MUnited Sta...
10.03.2026Slidesslide.com$120MUnited Sta...
15.01.2026CloudSEKcloudsek.com$29MIndia
24.12.2025Coinbaxcoinbax.com$4.2MUnited Sta...
24.09.2025P-Talptal.in$3MIndia
19.07.2024Aware Reco...awarerecoverycare.com-United Sta...
06.06.2024Trashietrashie.io--
04.06.2024Jonajona.health$5MUnited Sta...
Show more

Mentions in press and media 243

DateTitleDescription
15.06.2026Rejuvenate Bio Accelerates Gene Therapy with $6M Funding, Merck PartnershipRejuvenate Bio, a San Diego biotechnology innovator, secured $6 million in vital financing. This capital propels its pioneering gene therapy platform. The company targets age-related and chronic diseases. Focus areas include companion anima...
12.06.2026Rejuvenate Bio Closes $6 Million Financing And Strategic R&D Collaboration With Merck Animal HealthLifespan Vision Ventures announced that its portfolio company, Rejuvenate Bio, has completed a $6 million financing round and entered into a strategic research and development collaboration with Merck Animal Health, marking a key milestone ...
11.06.2026Lifespan Portfolio Company Rejuvenate Bio Closes $6 Million Financing and R&D Collaboration with Merck Animal HealthMilestone financing and R&D collaboration advances gene therapy programs targeting chronic and age-related diseases in companion animals. NORWALK, Conn., June 11, 2026 /PRNewswire/ -- Lifespan Vision Ventures (LVV), an investment firm f...
01.06.2026P2 Science Secures $23M to Propel Green Chemistry ExpansionP2 Science, a green chemistry pioneer, raised $23 million in an oversubscribed funding round. Sofinnova Partners led this significant investment. The capital will accelerate commercial growth across multiple sectors. New markets include aro...
28.05.2026Cypher AI: $2 Million Seed Raised To Build AI-Native Infrastructure For Life Science R&DCypher AI, a company building AI-native digital infrastructure for life science research and development, announced it has raised $2 million in seed funding led by MaC Venture Capital, with participation from Epsilon Ventures, Connecticut I...
27.05.2026Cypher AI Secures $2M to Scale AI-Native Infrastructure for Life Science R&D Beyond the Spreadsheets: Why Cypher AI Raised $2M to Re-Engineer the Biotech R&D StackWhat You Should Know Life science infrastructure startup Cypher AI has emerged from stealth, announcing a $2M seed funding round led by MaC Venture Capital. The financing includes strategic participation from Epsilon Ventures, Connecticut I...
27.05.2026Cypher AI Raises $2M in Seed FundingCypher AI, a Cambridge, MA-based company building AI-native digital infrastructure for life science R&D, raised $2M in Seed funding. The round was led by MaC Venture Capital, with participation from Epsilon Ventures, Connecticut Innovat...
26.05.2026P2 Science Raises $23 Million To Expand Green Chemistry Platform Into New MarketsP2 Science announced it has closed an oversubscribed $23 million funding round led by Sofinnova Partners to accelerate commercial growth and expand its green chemistry platform into new markets. The company said the financing will support t...
23.05.2026Neurosoft Bioelectronics Fuels BCI Revolution with $7.5M FundingNeurosoft Bioelectronics closed a $7.5 million seed round. This significant funding accelerates revolutionary stretchable brain-computer interfaces (BCIs). These minimally invasive devices offer unparalleled compliance and extensive cortica...
22.05.2026Neurosoft Bioelectronics: $7.5 Million Seed Round Closed To Advance Stretchable Brain-Computer InterfacesNeurosoft Bioelectronics announced it has closed a $7.5 million oversubscribed seed financing round to accelerate development of its stretchable and scalable brain-computer interface (BCI) platform. The funding will support the company’s mi...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In